Log In
BCIQ
Print this Print this
 

BCD-100

  Manage Alerts
Collapse Summary General Information
Company Biocad CJSC
DescriptionAnti-programmed cell death 1 (PD-1; PDCD1; CD279) mAb
Molecular Target Programmed cell death 1 (PD-1) (PDCD1) (CD279)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationMelanoma
Indication DetailsTreat skin melanoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today